Trexquant Investment LP Genmab A/S Transaction History

Trexquant Investment LP

  • $8.06 Billion
  • Q4 2024

A detailed history of Trexquant Investment LP transactions in Genmab A/S stock. As of the latest transaction made, Trexquant Investment LP holds 379,936 shares of GMAB stock, worth $8.27 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares
379,936
Previous 63,847 495.07%
Holding current value
$8.27 Million
Previous $1.56 Million 409.58%
% of portfolio
0.1%
Previous 0.02%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 12, 2025
BUY
$20.02 - $24.15 $6.33 Million - $7.63 Million
316,089 Added 495.07%
379,936 $7.93 Million
Q3 2024

Nov 12, 2024
BUY
$23.84 - $28.48 $1.25 Million - $1.49 Million
52,334 Added 454.56%
63,847 $1.56 Million
Q2 2024

Aug 13, 2024
SELL
$25.13 - $30.27 $1.4 Million - $1.68 Million
-55,600 Reduced 82.85%
11,513 $289,000
Q1 2024

May 14, 2024
SELL
$26.43 - $32.77 $2.27 Million - $2.82 Million
-85,985 Reduced 56.16%
67,113 $2.01 Million
Q4 2023

Feb 09, 2024
BUY
$27.94 - $35.44 $4.28 Million - $5.43 Million
153,098 New
153,098 $4.87 Million
Q1 2023

May 15, 2023
SELL
$34.88 - $43.22 $2.66 Million - $3.3 Million
-76,312 Reduced 71.13%
30,974 $1.17 Million
Q4 2022

Feb 13, 2023
BUY
$33.8 - $47.06 $3.23 Million - $4.5 Million
95,530 Added 812.61%
107,286 $4.55 Million
Q3 2022

Nov 14, 2022
BUY
$31.52 - $373.61 $370,549 - $4.39 Million
11,756 New
11,756 $378,000
Q2 2022

Aug 11, 2022
SELL
$26.83 - $38.57 $614,782 - $883,792
-22,914 Closed
0 $0
Q1 2022

May 13, 2022
SELL
$30.95 - $39.68 $768,024 - $984,659
-24,815 Reduced 51.99%
22,914 $829,000
Q4 2021

Feb 14, 2022
BUY
$35.87 - $47.12 $1.71 Million - $2.25 Million
47,729 New
47,729 $1.89 Million
Q2 2021

Aug 12, 2021
SELL
$32.88 - $44.57 $225,359 - $305,482
-6,854 Closed
0 $0
Q1 2021

May 13, 2021
BUY
$30.92 - $44.4 $211,925 - $304,317
6,854 New
6,854 $225,000
Q3 2020

Nov 06, 2020
SELL
$33.07 - $38.68 $736,601 - $861,558
-22,274 Closed
0 $0
Q2 2020

Aug 07, 2020
BUY
$20.05 - $33.89 $61,172 - $103,398
3,051 Added 15.87%
22,274 $755,000
Q1 2020

May 08, 2020
BUY
$17.15 - $25.22 $329,674 - $484,804
19,223 New
19,223 $407,000

Others Institutions Holding GMAB

# of Institutions
245
Shares Held
61.3M
Call Options Held
159K
Put Options Held
38K
View Full List

About GENMAB A/S

GMAB Quotes by TradingView
  • Ticker GMAB
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 658,292,992
  • Market Cap $14.3B
  • Description
  • Genmab A/S develops antibody therapeutics for the treatment of cancer and other diseases primarily in Denmark. The company markets DARZALEX, a human monoclonal antibody for the treatment of patients with multiple myeloma (MM); teprotumumab for the treatment of thyroid eye disease; ofatumurnab, a human monoclonal antibody to treat chronic lymphoc...
More about GMAB
Track This Portfolio

Track Trexquant Investment LP Portfolio

Follow Trexquant Investment LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Trexquant Investment LP, based on Form 13F filings with the SEC.

News

Stay updated on Trexquant Investment LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email